来自EudraVigilance数据库的贝伐珠单抗与帕尼单抗耐药性及无效性的真实世界证据
Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database
原文发布日期：16 February 2025
DOI: 10.3390/cancers17040663
类型: Article
开放获取: 是
英文摘要：
摘要翻译：
原文链接：
Colorectal cancer (CRC) is the third most common cancer in the world, with an average 5-year overall survival (OS) rate of approximately 60% [...]
结直肠癌是全球第三大常见恶性肿瘤，患者五年总生存率平均约为60%。
……
肿瘤(癌症)患者之家